GET Paper Withdrawal Shocks CBT/GET Proponents – Emboldens ME/CFS Advocates
Our mission is to promote evidence-informed health decision-making by producing high-quality, relevant, accessible systematic reviews and other synthesized research evidence. Our work is internationally recognized as the benchmark for high-quality information about...
On Your Marks GETSET: Don’t Go – Major Graded Exercise ME/CFS Trial Underwhelms (Again)
The Lancet — one of the most highly regarded journals in the world — is back on the chronic fatigue syndrome (ME/CFS) community’s front page. That’s probably enough to either elicit curses from ME/CFS patients or to produce a strong desire to...
Data analysis Puts PACE Chronic Fatigue Syndrome Trial on Slippery Slope to Retraction
The issue at stake was a big one. It asked whether changes to the original protocol of the PACE trial ended up stacking the deck. It was easy to see how they might have; some of the recovery criteria were so weird as to seem ridiculous. The changes in the studies...
Federal Report Says There’s (Almost) No Evidence CBT/GET Works in Chronic Fatigue Syndrome (ME/CFS)
This has a been good week for advocacy. It’s showing that smart advocacy works. Twice advocates went straight back into “the system” looking for results and twice – once with the PACE trial and here with AHRQ report in the U.S. – they...
The PACE Trial Gets Its Most Devastating Critique Yet
The PACE trial has taken its hits – plenty of them but it’s never taken a hit like this – a full blown critique by the head of a statistical organization. With it’s publisher Lancet still deflecting inquiries the PACE trial is still alive but...Lives Interrupted Latest Story
Allyn Archer
Atlanta, United States
Former occupation: Architect, Professor of Architecture
$2,768,291
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
